Antenatal screening for chromosomal abnormalities.
Kagan KO, Sonek J, Kozlowski P.
Arch Gynecol Obstet. 2022 Apr;305(4):825-835. doi: 10.1007/s00404-022-06477-5. Epub 2022 Mar 13.
Prenatal diagnosis of chromosomal aberrations by chromosomal microarray analysis and pregnancy outcomes of fetuses with polyhydramnios.
Liu Y, Hu T, Qian Y, Wang J, Hu R, Xiao L, Liao N, Liu Z, Wang H, Liu S, Zhang Z.
J Matern Fetal Neonatal Med. 2024 Dec;37(1):2344089. doi: 10.1080/14767058.2024.2344089. Epub 2024 May 6.
Copy number variations and fetal ventriculomegaly.
Wang Y, Hu P, Xu Z.
Curr Opin Obstet Gynecol. 2018 Apr;30(2):104-110. doi: 10.1097/GCO.0000000000000439.
Creating basis for introducing non-invasive prenatal testing in the Estonian public health setting.
Žilina O, Rekker K, Kaplinski L, Sauk M, Paluoja P, Teder H, Ustav EL, Tõnisson N, Reimand T, Ridnõi K, Palta P, Vermeesch JR, Krjutškov K, Kurg A, Salumets A.
Prenat Diagn. 2019 Dec;39(13):1262-1268. doi: 10.1002/pd.5578. Epub 2019 Nov 6.
Combined first-trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT.
Gadsbøll K, Vogel I, Kristensen SE, Pedersen LH, Hyett J, Petersen OB; Danish Cytogenetic Central Register study group.
Ultrasound Obstet Gynecol. 2024 Oct;64(4):470-479. doi: 10.1002/uog.27667. Epub 2024 Sep 4.
Machine learning-based evaluation of application value of the USM combined with NIPT in the diagnosis of fetal chromosomal abnormalities.
Xu X, Wang L, Cheng X, Ke W, Jie S, Lin S, Lai M, Zhang L, Li Z.
Math Biosci Eng. 2022 Feb 25;19(4):4260-4276. doi: 10.3934/mbe.2022197.
Where have all the trisomies gone?
Palomaki GE, Lambert-Messerlian GM, Haddow JE.
Am J Obstet Gynecol. 2016 Nov;215(5):583-587.e1. doi: 10.1016/j.ajog.2016.06.046.
Fetal Screening for Chromosomal Abnormalities.
Fiorentino DG, Hughes F.
Neoreviews. 2021 Dec 1;22(12):e805-e818. doi: 10.1542/neo.22-12-e805.
Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients.
Popescu F, Jaslow CR, Kutteh WH.
Hum Reprod. 2018 Apr 1;33(4):579-587. doi: 10.1093/humrep/dey021.
Clinical value of screening prenatal ultrasound combined with chromosomal microarrays in prenatal diagnosis of chromosomal abnormalities.
Jiang H, Kong X, Bian W, Liu J, Xu Y, Cui A, Cao X.
J Matern Fetal Neonatal Med. 2024 Dec;37(1):2324348. doi: 10.1080/14767058.2024.2324348. Epub 2024 Mar 11.
